{"transactions":[{"id":4618413,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T21:07:12.000Z","date":"2025-07-24","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":15,"value":3000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Stock held by Casey M. Tansey."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001193125-26-392111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000119312526392111/ownership.xml","form_type":"4/A","original_submission_date":"2025-07-24"}},{"id":1082203,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":1117743,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Stock held by USVP SFI, on its own behalf and as nominee for USVP SFI-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1117743},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082202,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":26993,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26993},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082201,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock Series B","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":41876,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41876},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082200,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series A Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":149655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149655},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082199,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":531877,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":531877},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082198,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series B Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":825135,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":825135},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082197,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series A Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":2948794,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2948794},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082196,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":1117743,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Stock held by USVP SFI, on its own behalf and as nominee for USVP SFI-A."}],"balance_after":1117743,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082195,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":26993,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":218524,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082194,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":41876,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":191531,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082193,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":149655,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":149655,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082192,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":531877,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":4305806,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082191,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":825135,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":3773929,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082190,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":2948794,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":2948794,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":2953584,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":54496,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII-A, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14677},"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953583,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":1073793,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":289198},"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953582,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series B Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":335417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII-A, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":90335},"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953581,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series B Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":6609027,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1779969},"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953580,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":47619,"price":21,"value":999999.0,"ownership":{"direct":false,"nature":"Directly owned by Tansey"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in the Issuer's initial public offering."}],"balance_after":47619,"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953579,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":14677,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":105012,"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953578,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":90335,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":90335,"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953577,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":289198,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2069167,"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}},{"id":2953576,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":144834,"kind":"organization","name":"U.S. Venture Partners XII-A, L.P.","position":3,"cik":"0001754875","reported_name":"U.S. Venture Partners XII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-09T02:04:04.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":1779969,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common  Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the \"USVP XII Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP XII.  Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1779969,"source":{"system":"sec-edgar","filing":"0001548538-20-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000154853820000027/edgar.xml","form_type":"4"}}]}